Form D — Crosslink Therapeutics Inc.
0002067583-25-000002 · filed 2025-05-15
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $8,000,000
- Total sold
- $4,250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Crosslink Therapeutics Inc.
- CIK
- 2067583
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 349-351 NEWBURY STREET
BOSTON, MA 02115 - Phone
- 404-861-1253
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ronald D. Seidel, III · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Andrew King · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Lou Tartaglia · DirectorBoston, MA Find on LinkedIn ↗
-
Rodolfo Chaparro · DirectorBoston, MA Find on LinkedIn ↗
-
Cameron Gallagher · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.